Practical considerations for personalized medicine in thyroid cancer: Which therapies are suited to particular patient profiles?
After watching this activity, participants should be better able to:
- Identify the different types of thyroid cancer and the recommended methods to test for specific biomarkers
- Evaluate the rationale and latest clinical evidence for current and emerging targeted therapies for thyroid cancer
- Outline the indications, precautions and special considerations related to targeted therapies for personalized thyroid cancer care
Internationally renowned medical oncologist Prof. Marcia S Brose explores the importance of molecular pathology and individual patient profiles in guiding personalized medicine in thyroid cancer to deliver optimal outcomes.
This activity is jointly provided by USF Health and touchIME. read more
Validated thyroid cancer specialists, including, oncologists, thyroid cancer specialists, oncology surgeons, endocrinologists, radiologists, pathologists and specialist oncology nurses involved in the management of thyroid cancer.
USF Health adheres to the Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to influence content have disclosed to USF Health any financial relationship with an ineligible organization. USF Health has reviewed and mitigated all relevant financial relationships related to the content of the activity. The relevant relationships are listed below. All individuals not listed have no relevant financial relationships.
Professor Marcia S Brose discloses: Advisory board or panel fees from Aadi Bioscience, Eisai and Eli Lilly (relationships terminated). Consultancy fees from Bayer Healthcare, Eisai (relationship terminated) and Exelixis (relationship terminated). Grants/research support from Eli Lilly and Kinnate Biopharma.
Alicia Canalejo, APRN, has no financial interests/relationships or affiliations in relation to this activity.
Touch Medical Contributor
Anne Nunn has no financial interests/relationships or affiliations in relation to this activity.
USF Health Office of Continuing Professional Development and touchIME staff have no financial interests/relationships or affiliations in relation to this activity.
Requirements for Successful Completion
In order to receive credit for this activity, participants must review the content and complete the post-test and evaluation form. Statements of credit are awarded upon successful completion of the post-test and evaluation form.
If you have questions regarding credit please contact firstname.lastname@example.org.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through a joint providership of USF Health and touchIME. USF Health is accredited by the ACCME to provide continuing medical education for physicians.
USF Health designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The European Union of Medical Specialists (UEMS) – European Accreditation Council for Continuing Medical Education (EACCME) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 CreditTM into European CME credit (ECMEC) should contact the UEMS (www.uems.eu).
Advanced Practice Providers
Physician Assistants may claim a maximum of 0.75 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society.
The AANPCP accepts certificates of participation for educational activities approved for AMA PRA Category 1 CreditTM by ACCME-accredited providers. APRNs who participate will receive a certificate of completion commensurate with the extent of their participation.
USF Health is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
A maximum of 0.75 contact hours may be earned by learners who successfully complete this continuing professional development activity. USF Health, the accredited provider, acknowledges touchIME as the joint provider in the planning and execution of this CNE activity.
This activity is awarded 0.75 ANCC pharmacotherapeutic contact hour.
Date of original release: 19 October 2023. Date credits expire: 19 October 2024.
If you have any questions regarding credit please contact email@example.com.
To obtain the CE/CME credit(s) from this activity, please complete this post-activity test.Claim Credit
You may also be interested in...
Advancing the management of adult solid tumours in 2023, and beyond: Unlocking the potential of radiopharmaceuticalsThis activity is CE/CME accredited
Julie Ann Sosa, MD, MA, FACS: American Thyroid Association (ATA) centennial celebration
Personalized treatment of RET-altered thyroid cancers: What is the value of biomarker testing and targeted therapies?This activity is CE/CME accredited
Lisanne de Koster, ETA 2021: FDG-PET/CT Prior to Diagnostic Thyroid Surgery
The Importance of the 2015 American Thyroid Association Guidelines for Adults with Thyroid Nodules and Differentiated Thyroid Cancer in Minimising Overdiagnosis and Overtreatment of Thyroid Carcinoma
How Iodide Reaches its Site of Utilisation in the Thyroid Gland Involvement of Solute Carrier 26A4 (Pendrin) and Solute Carrier 5A8 (Apical Iodide Transporter)
REGISTER NOW FOR FREE ACCESS TO
- 1000+ topical and insightful peer-reviewed journal articles
- 100+ hours of bite-sized congress highlights
- 10 major therapy areas packed with the latest scientific advances
- 150+ specialties offering learn-on-the-go medical education
- + Concise email updates and newsletters so you never miss out
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!